CMH — Chordate Medical Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK0.95m
- -SEK3.30m
- SEK0.66m
Brief: Chordate Says American Headache Society Accepts Presentation Of Pm007 Study Results
Brief: Chordate Medical Holding Q4 Pre-Tax Loss Widens To SEK 8.1 Mln
Brief: Chordate Medical Carries Out Directed Set-Off Share Issue
Brief: Chordate Medical Gets About SEK 36.7 Mln Through Rights Issue
Brief: Chordate Gets New Patent From European Patent Office
Brief: Chordate Medical Holding Receives Additional Subscription, Underwriting Commitments
Brief: Chordate Medical Distributor Ve.Di.SE Aims To Up Its Holding In Co
Brief: Chordate Enters Into Agreement With Janin In Riyadh
Brief: Chordate Medical Q3 Loss After Tax Widens To SEK 6.1 Mln
Brief: Chordate Medical Holding Proposes Rights Issue Of SEK 51.3 Mln
Brief: Statistical Significance Confirmed In Final Analysis Of Chordate’s PM007 Multicenter Clinical Study
Brief: Chordate Medical Provides Update From Pm007 Multicenter Clinical Study Of K.O.S-Stimulation
Brief: Chordate Medical Q2 Loss At SEK 6.0 Mln
Brief: Chordate Medical Enters Into Agreement With MTIGER
Brief: Chordate Medical Begins Market Introduction Of Migraine Treatment In Israel
Brief: Chordate Medical Announces Patent Protection For Headache Treatment In USA
Brief: Chordate Medical Holding Q1 Loss After Financial Items Widens To SEK 7.4 Mln
Brief: Chordate Medical Q4 Loss After Tax Widens To SEK 7.2 Mln
Brief: Chordate Medical Signs New Joint Venture Agreement With Nanos Medical In Shanghai